UK Vision Strategy claims sight loss is set to double

Article

Sight loss could double in the UK by the year 2050, according to predictions from eye health service UK Vision Strategy.

Sight loss could double in the UK by the year 2050, according to predictions from eye health service UK Vision Strategy.

Currently, one in five people aged 75 years and above have developed sight loss, compared to one in two people aged 90 years and above. Experts from the eye care and sight loss divisions are planning to identify improvements in diagnosis and find better treatments to avoid the predicted significant increase.

The UK Vision Strategy is a segment of the World Health Organisation's VISION 2020 initiative, which aspires to eliminate sight loss by the year 2020.

Chairperson of the UK Vision UK Vision Strategy and Chief Executive of Royal National Institute of Blind People, Lesley-Anne Alexander said, "Looking after your eyes by having regular checks is just as important as monitoring your blood pressure or paying a routine visit to the dentist. Problem teeth can usually be repaired or replaced but with eyes, the solution is rarely so simple. Whatever your age or health situation, if you haven't had your eyes checked recently, take action now and you could well prevent sight loss problems in later life".

Chairperson of VISION 2020 UK Nick Astbury, said, " Losing your sight should never become a naturally accepted part of getting older. Over half of all sight loss in this country can be avoided if it is picked up early and treated. Taking regular exercise, eating a healthy diet and stopping smoking is also vital for keeping your eyes healthy".

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.